[Characteristics and clinical use of immunostimulants].
Shirinskiĭ
V S
VS
Zhuk
E A
EA
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use; D008070:Lipopolysaccharides / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D012331:RNA, Fungal / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D008070:Lipopolysaccharides; D010455:Peptides; D010936:Plant Extracts; D012331:RNA, Fungal; D013949:Thymus Extracts; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007372:Interferons
Kharakteristika i klinicheskoe primenenie immunostimuliruiushchikh preparatov.